Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-178964
Filing Date
2025-08-12
Accepted
2025-08-12 16:17:17
Documents
64
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktx-20250630.htm   iXBRL 10-Q 2547771
2 EX-10.1 nktx-ex10_1.htm EX-10.1 31838
3 EX-31.1 nktx-ex31_1.htm EX-31.1 18072
4 EX-31.2 nktx-ex31_2.htm EX-31.2 17559
5 EX-32 nktx-ex32.htm EX-32 16984
6 GRAPHIC img34246019_0.jpg GRAPHIC 121976
  Complete submission text file 0001193125-25-178964.txt   9383348

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nktx-20250630.xsd EX-101.SCH 1063601
67 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20250630_htm.xml XML 1739895
Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

EIN.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39370 | Film No.: 251206965
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)